The University of Chicago Header Logo

Connection

Stephen Kent to HIV-1

Back to Details
This is a "connection" page, showing publications Stephen Kent has written about HIV-1.
Stephen Kent
Connection Strength
4.749
HIV-1
  1. Protective efficacy of the anti-HIV broadly neutralizing antibody PGT121 in the context of semen exposure. EBioMedicine. 2021 Aug; 70:103518.
    View in: PubMed
    Score: 0.629
  2. Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques. J Clin Invest. 2019 01 02; 129(1):182-191.
    View in: PubMed
    Score: 0.522
  3. Neutralizing Antibody-Based Prevention of Cell-Associated HIV-1 Infection. Viruses. 2018 06 18; 10(6).
    View in: PubMed
    Score: 0.506
  4. HIV Reactivation after Partial Protection by Neutralizing Antibodies. Trends Immunol. 2018 05; 39(5):359-366.
    View in: PubMed
    Score: 0.493
  5. Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment Interruption. J Virol. 2017 08 01; 91(15).
    View in: PubMed
    Score: 0.474
  6. NKG2D Acts as a Co-Receptor for Natural Killer Cell-Mediated Anti-HIV-1 Antibody-Dependent Cellular Cytotoxicity. AIDS Res Hum Retroviruses. 2016 Oct/Nov; 32(10-11):1089-1096.
    View in: PubMed
    Score: 0.447
  7. Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells. J Virol. 2016 02 15; 90(4):2021-30.
    View in: PubMed
    Score: 0.425
  8. Ionization state of the catalytic dyad Asp25/25' in the HIV-1 protease: NMR studies of site-specifically 13C labelled HIV-1 protease prepared by total chemical synthesis. Org Biomol Chem. 2012 Aug 14; 10(30):5887-91.
    View in: PubMed
    Score: 0.333
  9. Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progression. PLoS Pathog. 2024 12; 20(12):e1012739.
    View in: PubMed
    Score: 0.198
  10. Impact of HIV-1 viremia or sexually transmitted infection on semen-derived anti-HIV-1 antibodies and the immunosuppressive capacity of seminal plasma. Eur J Immunol. 2019 12; 49(12):2255-2258.
    View in: PubMed
    Score: 0.139
  11. Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1. Front Immunol. 2019; 10:1025.
    View in: PubMed
    Score: 0.135
  12. Two Families of Env Antibodies Efficiently Engage Fc-Gamma Receptors and Eliminate HIV-1-Infected Cells. J Virol. 2019 02 01; 93(3).
    View in: PubMed
    Score: 0.132
  13. Relationship between Measures of HIV Reactivation and Decline of the Latent Reservoir under Latency-Reversing Agents. J Virol. 2017 05 01; 91(9).
    View in: PubMed
    Score: 0.117
  14. HIV-specific antibody-dependent phagocytosis matures during HIV infection. Immunol Cell Biol. 2014 Sep; 92(8):679-87.
    View in: PubMed
    Score: 0.096
  15. Phenotypic and functional characteristics of highly differentiated CD57+NKG2C+ NK cells in HIV-1-infected individuals. Clin Exp Immunol. 2022 12 15; 210(2):163-174.
    View in: PubMed
    Score: 0.043
  16. Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope Vaccine. Hum Gene Ther. 2018 09; 29(9):1011-1028.
    View in: PubMed
    Score: 0.032
  17. Exploration of broadly neutralizing antibody fragments produced in bacteria for the control of HIV. Hum Vaccin Immunother. 2017 11 02; 13(11):2726-2737.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.